Physician profile
Young Williams
NPI 1801487111
$1,025.31
in general payments reported to CMS, 2019-2025
15 companies · $780 in 2025
The $780 reported for 2025 was more than what 76% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $245 · 2025: $780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $980 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $980.31 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $238.93 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Novo Nordisk INC | $230.83 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Exact Sciences Corporation | $85.98 | 2024-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.88 | 2024-2025 | Jardiance |
| Abbvie INC. | $78.35 | 2025 | |
| Dynavax Technologies Corporation | $49.90 | 2024-2025 | Heplisav-B |
| Pfizer INC. | $49.45 | 2024-2025 | |
| Astellas Pharma US INC | $46.93 | 2025 | Veozah |
| Boston Scientific Corporation | $38.45 | 2025 | General - Pain Management |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.70 | 2024-2025 | Xifaxan |
| Corcept Therapeutics | $21.29 | 2025 | Korlym |
| Ibsa Pharma INC. | $20.26 | 2025 | Tirosint, Flector, Licart |
| Actelion Pharmaceuticals US, INC. | $18.91 | 2025 | Opsumit, Uptravi |
| Glaxosmithkline, LLC. | $16.73 | 2025 | Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $15.72 | 2024 | Gardasil, Gardasil 9, Capvaxive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Young Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.